Northwestern Mutual Wealth Management CO Neurocrine Biosciences Inc Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 1,253 shares of NBIX stock, worth $140,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,253
Previous 1,137
10.2%
Holding current value
$140,235
Previous $130,000
31.54%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.13 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$547 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$338 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$284 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...